Guest Editorial: Warning Letters ? A Symptom?

BioPharm International, BioPharm International-03-15-2002, Volume 15, Issue 3

by Steven S. Kuwahara, Titan Pharmaceuticals Numerous warning letters and consent decrees have revealed problems in coping with even simple parts of the GMPs.